MedPath

Complementary Food Supplements for Reducing Childhood Undernutrition

Phase 2
Completed
Conditions
Stunting
Wasting
Interventions
Dietary Supplement: Chickpea based complementary food supplement
Dietary Supplement: Plumpy Doz
Dietary Supplement: Wheat Soy Blend (WSB++)
Dietary Supplement: Rice based complementary food supplement
Registration Number
NCT01562379
Lead Sponsor
Johns Hopkins Bloomberg School of Public Health
Brief Summary

The purpose of this study is to test the impact on child growth of three specially formulated complementary food supplements vs. Plumpy'Doz, a previously tested, commercially available complementary food, and vs. a control group that receives no food. All groups will receive nutrition education related to infant and young child feeding. This will be a cluster-randomised trial in children 6-18 months old in rural Rangpur and Gaibandha in Bangladesh.

Detailed Description

Childhood stunting and growth faltering is highly prevalent in South Asia. Among other strategies, adequate complementary feeding practices and provision of complementary foods that are appropriate and fill the nutrient gap by providing macro and micronutrients essential for growth are important means to reduce the global burden of undernutrition and related morbidity and mortality.

We propose to evaluate the impact of three complementary food supplement products that are fortified with micronutrients in a rural, remote setting in Bangladesh, where high rates of childhood undernutrition persist on child growth, health, and development. The three foods being tested are an enhanced wheat-soy blend (WSB++) developed by WFP, and locally developed chickpea-based and a rice-based complementary food supplements.

We will assess the impact of feeding these daily against the non-fed controls, hypothesizing that the children fed these foods show increased length for age Z scores (LAZ) and weight for length age Z scores (WLZ) of \>0.21 and decreased prevalence of stunting and wasting by \>10%. We expect that the impact of the three foods will be equivalent/ non-inferior to that of Plumpy'Doz.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5449
Inclusion Criteria
  • Infants 6 months of age
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Chickpea based complementary food supplementChickpea based complementary food supplementChildren will receive a Chickpea based complementary food supplement to be consumed daily.
Plumpy DozPlumpy DozIn this control arm children will receive prepackaged, lipid-based Plumpy'Doz (Nutriset, Mulaunay, France) for daily consumption as a snack.
Wheat Soy Blend (WSB++)Wheat Soy Blend (WSB++)Children will receive a WFP-developed Wheat-Soy Blend (WSB++) snack to be consumed daily.
Rice based complementary food supplementRice based complementary food supplementChildren will receive a locally developed rice based complementary food supplement.
Primary Outcome Measures
NameTimeMethod
Stunting in Children at 18 mo18 months of age

Prevalence of stunting at 18 months of age.

Secondary Outcome Measures
NameTimeMethod
Morbidityweekly from 6 to 18 months of age

weekly morbidity will be assessed for a year and episodes of diarrhea, dysentery ALRI, and fever will be recorded.

Intestinal FunctionAt 24 months of age

Intestinal function using L:M and other biomarkers will be assessed by intervention group and its association with child growth

Cognitive and Motor FunctionAt 18 months of age

Using Bayley III

Body CompositionAt 6, 9 and 12 months of age

Bioelectrical impedance analysis will be used to look at body composition changes from baseline until 18 months of age

Developmental MilestonesAt 6, 12, and 18 months of age

Age-specific developmental milestones will be assessed

Micronutrient Status18 months of age

Iron, vitamin A, zinc and other micronutrient status of children will be examined by intervention group.

Trial Locations

Locations (1)

The JiVitA Project, Johns Hopkins Bangladesh

🇧🇩

Gaibandha, Bangladesh

© Copyright 2025. All Rights Reserved by MedPath